iShares U.S. Pharmaceutical ETF (IHE)

NYSEArca

104.97
+1.89 (+1.83%)
Updated Aug 18, 5:45 PM ET
AI Rating
Buy
Overall Score
65
Trend
72
Momentum
54
Risk
68

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 120 sessions Aug 14, 2026

AI Analysis

iShares U.S. Pharmaceutical ETF is trading at $104.97, up 1.83% on the session. The 50 day average sits at $99.06 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 56.6, which reads as strong, and MACD is bearish crossover. Volume is below average.

The nearest support is around $99.66 with resistance near $103.70, so that band frames the current range. Average daily movement is roughly $1.74, or about 1.7% of the share price, which is what any stop placement has to allow for. The overall health score of 65 out of 100 combines a trend score of 72, momentum of 54 and a risk score of 68.

Technical indicators

RSI (14)
56.6
strong
MACD
1.076
bearish crossover
SMA 20
102.19
SMA 50
99.06
SMA 200
--
unknown
ATR (14)
1.74
avg daily range
Support
99.66
Resistance
103.70
Volume vs 20d
0.31x
below average
Volatility
16.1%
annualised
1 month
+2.53%
3 months
+14.67%

About iShares U.S. Pharmaceutical ETF

The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The fund is non-diversified.

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.